Id2 leaves the chromatin of the E2F4-p130-controlled c-myc promoter during hepatocyte priming for liver regeneration

The Id (inhibitor of DNA binding or inhibitor of differentiation) helix-loop-helix proteins are involved in the regulation of cell growth, differentiation and cancer. The fact that the molecular mechanisms of liver regeneration are not completely understood prompted us to study the fate of Id2 in pr...

Full description

Bibliographic Details
Authors: Rodriguez, J.L. (José L.)|||/items/fa2733a5-c7c0-4e99-9d41-64ee4cf1c54f, Sandoval, J. (Juan)|||/items/15e9a801-000b-48f9-8cc5-6747af534849, Serviddio, G. (Gaetano)|||/items/b725f3dc-afb5-4529-9f8a-7578ec11a8b8, Sastre, J. (Juan)|||/items/4f60e4a7-486b-48bb-ace1-2d07ab159b91, Morante, M. (María)|||/items/f86d8861-7b9e-405f-b0bb-47b4d652c2e1, Perrelli, M.J. (María-Giulia)|||/items/3c418076-9fb9-4f8f-a51a-2bd1d8bcee12, Martinez-Chantar, M.L. (María Luz)|||/items/df06120b-2a53-4074-a155-638f899b2ce5, Viña, J. (José)|||/items/3a94588e-f488-4d62-99b2-c639dc571e72, Mato, J.M. (José María)|||/items/302dc624-b0d3-4703-90cf-1a97690ebc79, Avila, M.A. (Matías Antonio)|||/items/3ad9abbb-c18d-445b-86cf-cb76be15419f, Franco, L. (Luis)|||/items/3ca4ede0-fdd2-4a83-a72f-b90cf9570816, Viña, J.R. (Juan R.)|||/items/28989225-9c39-4495-ae54-ba5fbb8f3963, Lopez-Rodas, G. (Gerardo)|||/items/32cdfe1e-70b1-48f3-8992-236a1d17bb83, Torres, L. (Luis)|||/items/e4740a05-e8bb-4f09-b3ca-e119dae6742b
Format: article
Publication Date:2006
Country:España
Institution:Universidad de Navarra
Repository:Dadun. Depósito Académico Digital de la Universidad de Navarra
Language:English
OAI Identifier:oai:dadun.unav.edu:10171/23244
Online Access:https://hdl.handle.net/10171/23244
Access Level:Open access
Keyword:Cell cycle
C-myc
E2F
Histone deacetylase
Id2
Liver regeneration
Description
Summary:The Id (inhibitor of DNA binding or inhibitor of differentiation) helix-loop-helix proteins are involved in the regulation of cell growth, differentiation and cancer. The fact that the molecular mechanisms of liver regeneration are not completely understood prompted us to study the fate of Id2 in proliferating liver. Id2 increases in liver regeneration after partial hepatectomy, following the early induction of its gene. Co-immunoprecipitation shows that Id2 forms a complex with E2F4, p130 and mSin3A in quiescent liver and all these components are present at the c-myc promoter as shown using ChIP (chromatin immunoprecipitation). Activation of c-myc during hepatocyte priming (G0-G1 transition) correlates with the dissociation of Id2 and HDAC (histone deacetylase), albeit p130 remains bound at least until 6 h. Moreover, as the G0-G1 transition progresses, Id2 and HDAC again bind the c-myc promoter concomitantly with the repression of this gene. The time course of c-myc binding to the Id2 promoter, as determined by ChIP assays is compatible with a role of the oncoprotein as a transcriptional inducer of Id2 in liver regeneration. Immunohistochemical analysis shows that Id2 also increases in proliferating hepatocytes after bile duct ligation. In this case, the pattern of Id2 presence in the c-myc promoter parallels that found in regenerating liver. Our results may suggest a control role for Id2 in hepatocyte priming, through a p130 dissociation-independent regulation of c-myc